210 related articles for article (PubMed ID: 34283174)
1. A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease.
Rampersaud E; Kang G; Palmer LE; Rashkin SR; Wang S; Bi W; Alberts NM; Anghelescu D; Barton M; Birch K; Boulos N; Brandow AM; Brooke RJ; Chang TC; Chen W; Cheng Y; Ding J; Easton J; Hodges JR; Kanne CK; Levy S; Mulder H; Patel AP; Puri L; Rosencrance C; Rusch M; Sapkota Y; Sioson E; Sharma A; Tang X; Thrasher A; Wang W; Yao Y; Yasui Y; Yergeau D; Hankins JS; Sheehan VA; Downing JR; Estepp JH; Zhang J; DeBaun M; Wu G; Weiss MJ
Blood Adv; 2021 Jul; 5(14):2839-2851. PubMed ID: 34283174
[TBL] [Abstract][Full Text] [Related]
2. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
[TBL] [Abstract][Full Text] [Related]
3. Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia
Heitzer AM; Longoria J; Rampersaud E; Rashkin SR; Estepp JH; Okhomina VI; Wang WC; Raches D; Potter B; Steinberg MH; King AA; Kang G; Hankins JS
Curr Res Transl Med; 2022 Jul; 70(3):103335. PubMed ID: 35303690
[TBL] [Abstract][Full Text] [Related]
4. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
[TBL] [Abstract][Full Text] [Related]
5. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania.
Mtatiro SN; Makani J; Mmbando B; Thein SL; Menzel S; Cox SE
Am J Hematol; 2015 Jan; 90(1):E1-4. PubMed ID: 25263325
[TBL] [Abstract][Full Text] [Related]
7. HbF-promoting polymorphisms may specifically reduce the residual risk of cerebral vasculopathy in SCA children with alpha-thalassemia.
Joly P; Bonello-Palot N; Badens C; Pissard S; Chamouine A; Bernaudin F; Bertrand Y; Connes P; Renoux C
Clin Hemorheol Microcirc; 2021; 77(3):267-272. PubMed ID: 33216016
[TBL] [Abstract][Full Text] [Related]
8. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS
Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141
[TBL] [Abstract][Full Text] [Related]
9. Identifying genetic variants and pathways associated with extreme levels of fetal hemoglobin in sickle cell disease in Tanzania.
Nkya S; Mwita L; Mgaya J; Kumburu H; van Zwetselaar M; Menzel S; Mazandu GK; Sangeda R; Chimusa E; Makani J
BMC Med Genet; 2020 Jun; 21(1):125. PubMed ID: 32503527
[TBL] [Abstract][Full Text] [Related]
10. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
Gueye Tall F; Martin C; Ndour EHM; Renoux C; Ly ID; Connes P; Gueye PM; Diallo RN; Diagne I; Diop PA; Cissé A; Lopez Sall P; Joly P
Pediatr Blood Cancer; 2019 Oct; 66(10):e27934. PubMed ID: 31322815
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon.
Wonkam A; Mnika K; Ngo Bitoungui VJ; Chetcha Chemegni B; Chimusa ER; Dandara C; Kengne AP
Br J Haematol; 2018 Jan; 180(1):134-146. PubMed ID: 29205277
[TBL] [Abstract][Full Text] [Related]
12.
Gardner K; Fulford T; Silver N; Rooks H; Angelis N; Allman M; Nkya S; Makani J; Howard J; Kesse-Adu R; Rees DC; Stuart-Smith S; Yeghen T; Awogbade M; Sangeda RZ; Mgaya J; Patel H; Newhouse S; Menzel S; Thein SL
Blood Adv; 2018 Feb; 2(3):235-239. PubMed ID: 29437638
[TBL] [Abstract][Full Text] [Related]
13. Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemia.
Bean CJ; Boulet SL; Yang G; Payne AB; Ghaji N; Pyle ME; Hooper WC; Bhatnagar P; Keefer J; Barron-Casella EA; Casella JF; Debaun MR
Br J Haematol; 2013 Oct; 163(2):268-76. PubMed ID: 23952145
[TBL] [Abstract][Full Text] [Related]
14. Genetics of fetal hemoglobin in tribal Indian patients with sickle cell anemia.
Bhanushali AA; Patra PK; Pradhan S; Khanka SS; Singh S; Das BR
Transl Res; 2015 Jun; 165(6):696-703. PubMed ID: 25651163
[TBL] [Abstract][Full Text] [Related]
15. Fetal hemoglobin in sickle cell anemia: Bayesian modeling of genetic associations.
Sebastiani P; Wang L; Nolan VG; Melista E; Ma Q; Baldwin CT; Steinberg MH
Am J Hematol; 2008 Mar; 83(3):189-95. PubMed ID: 17918249
[TBL] [Abstract][Full Text] [Related]
16. Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models.
Milton JN; Gordeuk VR; Taylor JG; Gladwin MT; Steinberg MH; Sebastiani P
Circ Cardiovasc Genet; 2014 Apr; 7(2):110-5. PubMed ID: 24585758
[TBL] [Abstract][Full Text] [Related]
17. Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer.
Mtatiro SN; Mgaya J; Singh T; Mariki H; Rooks H; Soka D; Mmbando B; Thein SL; Barrett JC; Makani J; Cox SE; Menzel S
BMC Med Genet; 2015 Feb; 16():4. PubMed ID: 25928412
[TBL] [Abstract][Full Text] [Related]
18. Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.
Kirkham JK; Estepp JH; Weiss MJ; Rashkin SR
JAMA Netw Open; 2023 Oct; 6(10):e2337484. PubMed ID: 37851445
[TBL] [Abstract][Full Text] [Related]
19. Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.
Hankins JS; Estepp JH; Hodges JR; Villavicencio MA; Robison LL; Weiss MJ; Kang G; Schreiber JE; Porter JS; Kaste SC; Saving KL; Bryant PC; Deyo JE; Nottage KA; King AA; Brandow AM; Lebensburger JD; Adesina O; Chou ST; Zemel BS; Smeltzer MP; Wang WC; Gurney JG
Pediatr Blood Cancer; 2018 Sep; 65(9):e27228. PubMed ID: 29797644
[TBL] [Abstract][Full Text] [Related]
20. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
